A structural comparison of inhibitor binding to PKB, PKA and PKA-PKB chimera
about
Phosphatidylinositol 3-kinase and antiestrogen resistance in breast cancerInsights into the Conformational Variability and Regulation of Human Nek2 KinaseDiscovery of 4-Amino-1-(7 H -pyrrolo[2,3- d ]pyrimidin-4-yl)piperidine-4-carboxamides As Selective, Orally Active Inhibitors of Protein Kinase B (Akt)Structural and Functional Analyses of the Second-Generation Integrase Strand Transfer Inhibitor Dolutegravir (S/GSK1349572)Mutants of protein kinase A that mimic the ATP-binding site of Aurora kinaseCrystal Structure of a Human I B Kinase Asymmetric DimerThe discovery of potent ribosomal S6 kinase inhibitors by high-throughput screening and structure-guided drug designCrystal structure of human CDC7 kinase in complex with its activator DBF4Addressing the Glycine-Rich Loop of Protein Kinases by a Multi-Facetted Interaction Network: Inhibition of PKA and a PKB MimicEngineering archeal surrogate systems for the development of protein-protein interaction inhibitors against human RAD51Trisubstituted-Imidazoles Induce Apoptosis in Human Breast Cancer Cells by Targeting the Oncogenic PI3K/Akt/mTOR Signaling PathwayQuantum mechanical pairwise decomposition analysis of protein kinase B inhibitors: validating a new tool for guiding drug designChiral kinase inhibitors.Discovery of novel anticancer therapeutics targeting the PI3K/Akt/mTOR pathway.Advances in fragment-based drug discovery platforms.Resistance of Akt kinases to dephosphorylation through ATP-dependent conformational plasticity.Clinical development of phosphatidylinositol-3 kinase pathway inhibitorsProtein kinase-inhibitor database: structural variability of and inhibitor interactions with the protein kinase P-loop.Preclinical pharmacology, antitumor activity, and development of pharmacodynamic markers for the novel, potent AKT inhibitor CCT128930.Measuring and interpreting the selectivity of protein kinase inhibitorsAutoregulation of kinase dephosphorylation by ATP binding in AGC protein kinases.Akt kinase C-terminal modifications control activation loop dephosphorylation and enhance insulin responseBinding selectivity studies of PKBα using molecular dynamics simulation and free energy calculations.AT7867 is a potent and oral inhibitor of AKT and p70 S6 kinase that induces pharmacodynamic changes and inhibits human tumor xenograft growth.Inhibitor hijacking of Akt activation.AKT capture by feline leukemia virus.Synthesis and evaluation of indazole based analog sensitive Akt inhibitorsRationally designed PKA inhibitors for positron emission tomography: Synthesis and cerebral biodistribution of N-(2-(4-bromocinnamylamino)ethyl)-N-[11C]methyl-isoquinoline-5-sulfonamide.Theory of docking scores and its application to a customizable scoring function.In search of AKT kinase inhibitors as anticancer agents: structure-based design, docking, and molecular dynamics studies of 2,4,6-trisubstituted pyridines.
P2860
Q26862550-25C7AF12-D0AB-41DC-96BF-BC27819D6370Q27653344-30FD7ECF-34C8-4150-B5FE-32EBBF78B357Q27659777-D8D36D76-BF20-4126-B6A9-4C9B31AB544DQ27670616-AD474D12-CED8-4C73-88AD-41D3F5C39983Q27670889-23DFAF61-1B78-4C7F-AC67-39C9F6D446FDQ27678740-F5DEAC92-6B79-4725-8598-8CBB01E942AAQ27680079-B78958B5-ED95-44E7-AE1B-5A2FED49C908Q27682804-6FA1C895-200E-435F-8FDA-643B5D526C65Q27702642-54B33C46-F286-4F5A-AD0A-BB2A3F109EE5Q27728438-618A1841-661B-4FB3-B613-FDA98E74839BQ28551465-75BFB6E3-651F-4CDB-A612-0C6CFAE168DEQ33390338-7E3BEFCC-57AA-4153-8797-CF653EAE4644Q33811207-1AFB6CBB-73BA-413B-99DD-461A7F75D006Q33852403-988CEB77-4C32-4FD1-8229-E76910852ACBQ34616682-168D0500-E6B5-4DE9-BB20-7CEE4E6DE507Q35558850-A1F13EFF-5F43-4A19-BC25-1955D58F09EFQ35566234-64DAD0C5-7B07-4343-8D77-35FBB38EEC26Q35606325-6632FA03-878F-4B53-9F93-60A49043EF68Q37094837-7C752795-932E-4AAD-9254-1BFBB4BCB6C8Q37537075-AB4F7BE9-EAC1-4138-97CC-1B1945D66C19Q37977357-4E828B14-B9D1-406A-9BC3-CE0EBA80D09CQ38850409-52CA48E8-4857-42D0-A14D-EED8DAE3785AQ39340926-4EB3F76D-A05D-450F-B71D-6FF69C085A92Q39710160-9986A34A-372E-41A9-AB81-25B918A51782Q39847621-169C38A2-BFE2-47F0-890D-F5E8CB606A57Q40399045-DEEBC1E9-F9B2-46CA-BBA1-D81AA81A0085Q42153180-B9E6AC83-0D8F-4F0E-B7B2-2DAEA4E78A94Q42319599-817680F2-45F0-4645-B1C2-342348F90CA1Q44825264-F8C07341-2356-47A8-9592-ADEBE3A87628Q48285395-66C7F541-3600-4137-9709-E2FA9B4D3692
P2860
A structural comparison of inhibitor binding to PKB, PKA and PKA-PKB chimera
description
2007 nî lūn-bûn
@nan
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
A structural comparison of inhibitor binding to PKB, PKA and PKA-PKB chimera
@ast
A structural comparison of inhibitor binding to PKB, PKA and PKA-PKB chimera
@en
A structural comparison of inhibitor binding to PKB, PKA and PKA-PKB chimera
@en-gb
A structural comparison of inhibitor binding to PKB, PKA and PKA-PKB chimera
@nl
type
label
A structural comparison of inhibitor binding to PKB, PKA and PKA-PKB chimera
@ast
A structural comparison of inhibitor binding to PKB, PKA and PKA-PKB chimera
@en
A structural comparison of inhibitor binding to PKB, PKA and PKA-PKB chimera
@en-gb
A structural comparison of inhibitor binding to PKB, PKA and PKA-PKB chimera
@nl
prefLabel
A structural comparison of inhibitor binding to PKB, PKA and PKA-PKB chimera
@ast
A structural comparison of inhibitor binding to PKB, PKA and PKA-PKB chimera
@en
A structural comparison of inhibitor binding to PKB, PKA and PKA-PKB chimera
@en-gb
A structural comparison of inhibitor binding to PKB, PKA and PKA-PKB chimera
@nl
P2093
P3181
P1476
A structural comparison of inhibitor binding to PKB, PKA and PKA-PKB chimera
@en
P2093
Brent Graham
Christopher C F Hamlett
David Barford
Harren Jhoti
Ian Collins
Marcel L Verdonk
Michelle D Garrett
Steven J Woodhead
Susanne Saalau-Bethell
Tatiana McHardy
P304
P3181
P356
10.1016/J.JMB.2007.01.004
P407
P50
P577
2007-03-30T00:00:00Z